News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
629,743 Results
Type
Article (23792)
Company Profile (189)
Press Release (605748)
Multimedia
Podcasts (37)
Webinars (18)
Section
Business (201825)
Career Advice (780)
Deals (30071)
Drug Delivery (54)
Drug Development (73741)
Employer Resources (58)
FDA (14312)
Job Trends (11826)
News (300112)
Policy (25162)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1803)
Accelerated approval (43)
ADA (45)
Adcomms (17)
Allergies (181)
Alliances (43564)
ALS (209)
Alzheimer's disease (1637)
Antibody-drug conjugate (ADC) (486)
Approvals (14938)
Artificial intelligence (707)
ASCO (271)
Autoimmune disease (340)
Automation (61)
Bankruptcy (297)
Best Places to Work (9538)
BIO (62)
BIOSECURE Act (7)
Biosimilars (176)
Biotechnology (122)
Bladder cancer (195)
Brain cancer (72)
Breast cancer (747)
Cancer (5839)
Cardiovascular disease (435)
Career advice (680)
Career pathing (25)
CAR-T (313)
CDC (22)
Celiac Disease (3)
Cell therapy (873)
Cervical cancer (48)
Clinical research (66154)
Collaboration (2071)
Commercialization (2)
Company closure (3)
Compensation (1465)
Complete response letters (71)
COVID-19 (1781)
CRISPR (110)
C-suite (1130)
Cystic fibrosis (144)
Data (8387)
Decentralized trials (2)
Denatured (19)
Depression (169)
Dermatology (90)
Diabetes (566)
Diagnostics (5902)
Digital health (60)
Diversity (9)
Diversity, equity & inclusion (16)
Drug discovery (348)
Drug pricing (52)
Drug shortages (6)
Duchenne muscular dystrophy (246)
Earnings (81005)
Editorial (28)
Employer branding (9)
Employer resources (62)
Events (108132)
Executive appointments (997)
FDA (18284)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (31)
Funding (1687)
Gene editing (224)
Generative AI (65)
Gene therapy (643)
GLP-1 (723)
Government (2497)
Grass and pollen (4)
Guidances (364)
Healthcare (14407)
Hematology (164)
HIV (78)
Huntington's disease (58)
IgA nephropathy (107)
Immunology and inflammation (222)
Immuno-oncology (97)
Indications (208)
Infectious disease (2088)
Inflammatory bowel disease (190)
Inflation Reduction Act (6)
Influenza (129)
Intellectual property (316)
Interviews (118)
IPO (14294)
IRA (14)
Job creations (2695)
Job search strategy (576)
JPM (28)
Kidney cancer (22)
Labor market (28)
Layoffs (257)
Leadership (23)
Legal (6101)
Licensing (1)
Liver cancer (82)
Longevity (29)
Lung cancer (793)
Lymphoma (413)
Machine learning (59)
Management (24)
Manufacturing (908)
Marketing (10)
MASH (194)
Medical affairs (1)
Medical device (12513)
Medtech (12700)
Mergers & acquisitions (16982)
Metabolic disorders (1303)
mRNA (155)
Multiple sclerosis (185)
NASH (12)
Neurodegenerative disease (425)
Neuropsychiatric disorders (85)
Neuroscience (3150)
Neurotech (1)
NextGen: Class of 2026 (4792)
Non-profit (2806)
Now hiring (20)
Obesity (507)
Opinion (175)
Ovarian cancer (232)
Pain (252)
Pancreatic cancer (334)
Parkinson's disease (359)
Partnered (29)
Patents (593)
Patient recruitment (804)
Peanut (64)
People (52445)
Pharmaceutical (43)
Pharmacy benefit managers (15)
Phase 1 (21016)
Phase 2 (29392)
Phase 3 (21025)
Pipeline (9693)
Policy (134)
Postmarket research (2156)
Preclinical (8752)
Press Release (60)
Prostate cancer (295)
Psychedelics (47)
Radiopharmaceuticals (293)
Rare diseases (1058)
Real estate (4667)
Recruiting (24)
Regulatory (21722)
Reports (25)
Research institute (1870)
Resumes & cover letters (123)
Rett syndrome (44)
RNA editing (20)
RSV (65)
Schizophrenia (159)
Series A (300)
Series B (215)
Service/supplier (4)
Sickle cell disease (109)
Special edition (4)
Spinal muscular atrophy (151)
Sponsored (37)
Startups (3032)
State (2)
Stomach cancer (8)
Supply chain (89)
Tariffs (13)
The Weekly (17)
Vaccines (739)
Venture capital (75)
Weight loss (259)
Women's health (122)
Worklife (6)
Date
Today (97)
Last 7 days (425)
Last 30 days (1768)
Last 365 days (27831)
2026 (16234)
2025 (26978)
2024 (31067)
2023 (35349)
2022 (45018)
2021 (48558)
2020 (45087)
2019 (35857)
2018 (26997)
2017 (26951)
2016 (25900)
2015 (32069)
2014 (27132)
2013 (22743)
2012 (24618)
2011 (25115)
2010 (23939)
Location
Africa (453)
Alabama (91)
Alaska (5)
Arizona (356)
Arkansas (14)
Asia (30235)
Australia (4700)
California (13823)
Canada (3695)
China (1214)
Colorado (573)
Connecticut (557)
Delaware (354)
Europe (62509)
Florida (2047)
Georgia (442)
Hawaii (5)
Idaho (52)
Illinois (984)
India (71)
Indiana (459)
Iowa (21)
Japan (536)
Kansas (126)
Kentucky (42)
Louisiana (55)
Maine (85)
Maryland (1526)
Massachusetts (9876)
Michigan (336)
Minnesota (737)
Mississippi (7)
Missouri (131)
Montana (33)
Nebraska (25)
Nevada (148)
New Hampshire (81)
New Jersey (3336)
New Mexico (28)
New York (3544)
North Carolina (1646)
North Dakota (8)
Northern California (7013)
Ohio (401)
Oklahoma (24)
Oregon (35)
Pennsylvania (2674)
Puerto Rico (29)
Rhode Island (45)
South America (658)
South Carolina (82)
South Dakota (1)
Southern California (5554)
Tennessee (185)
Texas (2219)
United States (47471)
Utah (413)
Vermont (2)
Virginia (310)
Washington D.C. (57)
Washington State (1084)
West Virginia (2)
Wisconsin (121)
Wyoming (1)
629,743 Results for "alfa scientific designs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis
June 4, 2026
·
4 min read
Press Releases
Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions
June 1, 2026
·
3 min read
Press Releases
Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
April 15, 2026
·
3 min read
Press Releases
Marengo Secures ESMO 2026 Oral Presentation for Key Phase 2 Invikafusp Alfa Data in PD-1-Resistant Solid Tumors and Appoints Pembrolizumab Development Leader Eric Rubin, M.D., to Scientific Advisory Board
July 20, 2026
·
5 min read
Press Releases
PharmaEssentia Announces Health Canada Approval of BESREMi® (ropeginterferon alfa-2b) for Polycythemia Vera (PV)
July 6, 2026
·
6 min read
Press Releases
Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor
July 14, 2026
·
3 min read
Press Releases
PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen™ (ropeginterferon alfa-2b-njft) for Polycythemia Vera
June 26, 2026
·
5 min read
Press Releases
New Nature Communications Publication Highlights Efsubaglutide Alfa’s Effects on Glycaemia and β-Cell Function
May 13, 2026
·
2 min read
Press Releases
Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients
May 28, 2026
·
4 min read
Press Releases
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema
December 17, 2025
·
6 min read
1 of 62,975
Next
